Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | 0 | Inhibition of Escherichia coli DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 1.1 | Selectivity ratio of IC50 for rat liver DHFR to IC50 for Toxoplasma gondii DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 3.8 mM | Inhibition of Toxoplasma gondii DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 3.8 mM | Inhibition of Toxoplasma gondii DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 4 mM | Inhibition of rat liver DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 4 mM | Inhibition of rat liver DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 12 mM | Inhibition of Mycobacterium avium DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 12 mM | Inhibition of Mycobacterium avium DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 20.6 mM | Inhibition of Pneumocystis carinii DHFR | ChEMBL. | 17552508 |
IC50 (binding) | = 20.6 mM | Inhibition of Pneumocystis carinii DHFR | ChEMBL. | 17552508 |
IC50 (binding) | > 28 uM | Inhibition of human DHFR | ChEMBL. | 17552508 |
IC50 (binding) | > 28 uM | Inhibition of human DHFR | ChEMBL. | 17552508 |
Inhibition (binding) | = 30 % | Inhibition of human DHFR relative to control | ChEMBL. | 17552508 |
Inhibition (binding) | = 30 % | Inhibition of human DHFR relative to control | ChEMBL. | 17552508 |
Ratio IC50 (binding) | 0 | Selectivity ratio of IC50 for human DHFR to IC50 for Escherichia coli DHFR | ChEMBL. | 17552508 |
Ratio IC50 (binding) | = 0.2 | Selectivity ratio of IC50 for rat liver DHFR to IC50 for Pneumocystis carinii DHFR | ChEMBL. | 17552508 |
Ratio IC50 (binding) | = 0.33 | Selectivity ratio of IC50 for rat liver DHFR to IC50 for Mycobacterium avium DHFR | ChEMBL. | 17552508 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.